Physician
Yogesh Trakru MD
Yogesh Trakru MD was paid $9.67M by Medicaid between Jan 2018 and Dec 2024, across 85 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 23% of everything it billed.
33Billing provider infoYOGESH TRAKRU MD
BROWNSVILLE, TX 78521
BROWNSVILLE, TX 78521
33aNPI1487081279assigned 10/11/2013
33bProvider typePediatrics Physician
28Total paid$9.67M
24GClaims350,506
24DCodes billed85
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#26 of 1,136
Median peer was paid$329K
This provider vs. median29×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 705 | $23K | |
| 2019 | 339 | $8K | |
| 2020 | 12,240 | $273K | |
| 2021 | 83,634 | $2.24M | |
| 2022 | 98,202 | $2.80M | |
| 2023 | 85,916 | $2.38M | |
| 2024incomplete | 69,470 | $1.94M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 63,092 | 55,159 | $2.25M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 24,410 | 22,362 | $1.22M |
| 87428 | 10% | 14,110 | 13,331 | $976K | |
| S8301 | Infection control supplies, not otherwise specified | 9.7% | 36,793 | 31,923 | $942K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 8.1% | 19,738 | 18,656 | $781K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.7% | 5,716 | 5,596 | $457K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.5% | 5,392 | 5,103 | $433K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.4% | 5,571 | 5,423 | $423K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.1% | 4,039 | 3,790 | $300K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.9% | 26,064 | 12,229 | $283K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.2% | 15,873 | 7,670 | $215K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 25,463 | 23,803 | $162K |
73 more codes
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.5% | 1,140 | $147K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 10,498 | $141K |
| 99429 | 1.4% | 4,204 | $139K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 4,185 | $102K |
| 99000 | <1% | 9,242 | $92K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,418 | $74K |
| 99050 | <1% | 4,956 | $70K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 719 | $57K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,173 | $43K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 5,271 | $42K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 717 | $42K |
| 94010 | <1% | 1,619 | $35K | |
| 90461 | <1% | 6,310 | $27K | |
| 0001A | <1% | 676 | $26K | |
| 0002A | <1% | 598 | $24K | |
| 0071A | <1% | 495 | $19K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,035 | $14K |
| 0072A | <1% | 319 | $12K | |
| 96160 | <1% | 5,298 | $11K | |
| 81002 | <1% | 3,673 | $10K | |
| 97170 | <1% | 205 | $9K | |
| 99051 | <1% | 3,487 | $8K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 759 | $8K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 101 | $8K |
| 86318 | <1% | 487 | $8K | |
| 90651 | <1% | 1,147 | $7K | |
| 90677 | <1% | 691 | $5K | |
| 92567 | <1% | 366 | $5K | |
| 0081A | <1% | 132 | $5K | |
| 0003A | <1% | 110 | $4K | |
| 86580 | <1% | 505 | $4K | |
| 90686 | <1% | 3,064 | $4K | |
| 0053A | <1% | 88 | $3K | |
| 90620 | <1% | 1,042 | $3K | |
| 86328 | <1% | 74 | $3K | |
| 87634 | <1% | 52 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 297 | $3K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 28 | $2K |
| 0073A | <1% | 30 | $1K | |
| 97169 | <1% | 47 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 19 | $923.68 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,429 | $860.43 |
| 0082A | <1% | 19 | $760.00 | |
| 81007 | <1% | 29 | $730.22 | |
| 93000 | <1% | 60 | $667.19 | |
| 82016 | <1% | 52 | $664.80 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 25 | $660.38 |
| 82128 | <1% | 52 | $559.20 | |
| 69209 | <1% | 38 | $432.27 | |
| 96380 | <1% | 16 | $305.44 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,190 | $140.76 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,097 | $99.80 |
| 84030 | <1% | 27 | $92.40 | |
| 90656 | <1% | 773 | $87.35 | |
| 90685 | <1% | 85 | $42.00 | |
| 90648 | 0% | 2,884 | $0.00 | |
| 90700 | 0% | 228 | $0.00 | |
| 90633 | 0% | 1,253 | $0.00 | |
| 90670 | 0% | 2,245 | $0.00 | |
| 91300 | 0% | 1,429 | $0.00 | |
| 90734 | 0% | 1,090 | $0.00 | |
| 90710 | 0% | 1,187 | $0.00 | |
| 90715 | 0% | 128 | $0.00 | |
| 90655 | 0% | 51 | $0.00 | |
| 90380 | 0% | 16 | $0.00 | |
| 91308 | 0% | 210 | $0.00 | |
| 90680 | 0% | 1,754 | $0.00 | |
| 90723 | 0% | 2,026 | $0.00 | |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | 0% | 69 | $0.00 |
| 90696 | 0% | 228 | $0.00 | |
| 91307 | 0% | 1,049 | $0.00 | |
| 91305 | 0% | 212 | $0.00 | |
| 91301 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTRAKRU, YOGESH (PRESIDENT)